(2 of 2)
Some victims were horrified at the prospect of holding stock in the company that caused them trauma, but, Medica argued, that might be the only way to generate enough money to compensate them. Investors felt saved. Sulzer Medica shares jumped 19% on Aug. 29, the day after a U.S. district judge gave the $780 million plan a preliminary nod. "If it holds, it will be replicated," says John Aldock, a Washington corporate defense attorney. Don't worry about Scruggs putting himself out of business. If the deal holds, he could receive as much as $25 million.
TIME.com For more stories on the clash of business cultures, please visit our website at time.com/global.com